{"id":"W4378952054","doi":"10.3324/haematol.2023.282781","title":"Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy","year":2023,"lang":"en","type":"article","venue":"Haematologica","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Jazz Pharmaceuticals; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; Amgen; StemCyte; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Department of Health and Human Services","keywords":"Medicine; Population; Confidence interval; Transplantation; Internal medicine; Aplastic anemia; Standardized mortality ratio; Hematopoietic stem cell transplantation; Hematopoietic cell; Surgery; Haematopoiesis; Bone marrow; Stem cell","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002069105,0.0003294761,0.0003966402,0.001110782,0.0001253549,0.0003535269,0.0003862768,0.0003714327,0.001993943],"category_scores_gemma":[0.006361023,0.0001676663,0.001269105,0.0007960981,0.0002387526,0.0006309602,0.0005430689,0.0008809201,0.0002077832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002589443,"about_ca_system_score_gemma":0.00026871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003857846,"about_ca_topic_score_gemma":0.003170233,"domain_scores_codex":[0.9991508,0.0002686723,0.0000962699,0.0002513916,0.0001127208,0.0001202979],"domain_scores_gemma":[0.9925368,0.002526966,0.003464543,0.000540686,0.0004249553,0.0005060293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009434248,0.00002766904,0.9921328,0.00005079554,0.0008268241,0.00006722241,0.00004514528,0.001177013,0.0002506088,0.0002406044,0.0007068536,0.003530893],"study_design_scores_gemma":[0.0000334405,0.0004653919,0.9939299,0.00001418348,0.0003915231,0.000509766,0.0001091604,0.003610297,0.0002149123,0.0002170948,0.0004842315,0.00002021931],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993874,0.0009046234,0.0005376588,0.00008844165,0.00002262406,0.00001106855,0.003643228,0.00003628711,0.0008822136],"genre_scores_gemma":[0.9954888,0.0001879423,0.0002075172,0.00003087682,0.00003790843,0.00001555379,0.003840113,0.000005125751,0.0001861549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003857846,"threshold_uncertainty_score":0.01094258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02402665173448778,"score_gpt":0.2587644458449191,"score_spread":0.2347377941104314,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}